Treace(US:TMCI) Globenewswire·2025-10-23 20:05Core Insights - Treace Medical Concepts, Inc. will release its financial results for Q3 2025 on November 6, 2025, after market close, followed by a conference call at 4:30 pm ET to discuss the results [1] Company Overview - Treace Medical Concepts is focused on advancing surgical treatment standards for bunions and related midfoot deformities, affecting approximately 65 million Americans, with an estimated 1.1 million being surgical candidates annually [4] - The company has developed the patented Lapiplasty 3D Bunion Correction System, which addresses the root cause of bunions by correcting deformities in three planes and stabilizing the affected joint [4] - Treace has introduced additional systems such as the Adductoplasty Midfoot Correction System, SpeedMTP Rapid Compression Implant, and minimally invasive options like the Nanoplasty and Percuplasty systems to cater to various surgical needs [4] - The company is expanding its presence in the foot and ankle market with innovative products like the SpeedPlate Rapid Compression Implants, which offer versatility across multiple surgical procedures [4]